drugset

drugset / Trial / NCT01707537

To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men

NCT01707537 ↗

Phase 1 Completed 20 enrolled EuBiologics Co.,Ltd Instituto Universitario IVI · collab

NaSingle-groupOpen-labelPrevention

Summary

To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men

Timeline

Start: 2012-09
Primary completion: 2013-02
Completion: 2013-02

Publications

Baik YO, Choi SK, Kim JW, Yang JS, Kim IY, Kim CW, Hong JH. Safety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea. J Korean Med Sci. 2014 Apr;29(4):494-501. doi: 10.3346/jkms.2014.29.4.494. Epub 2014 Apr 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Euvichol	Vaccine	1.5 ml	Oral

Indications

No indication recorded.